Advertisement
Advertisement

PROF

PROF logo

Profound Medical Corp. Common Stock

6.46
USD
Sponsored
-0.05
-0.75%
Jun 25, 12:36 UTC -4
Open

PROF Earnings Reports

Positive Surprise Ratio

PROF beat 16 of 41 last estimates.

39%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$4.92M
/
-$0.26
Implied change from Q1 26 (Revenue/ EPS)
-7.90%
/
+36.84%
Implied change from Q2 25 (Revenue/ EPS)
+122.31%
/
-50.00%

Profound Medical Corp. Common Stock earnings per share and revenue

On May 07, 2026, PROF reported earnings of -0.19 USD per share (EPS) for Q1 26, beating the estimate of -0.25 USD, resulting in a 25.75% surprise. Revenue reached 5.34 million, compared to an expected 5.02 million, with a 6.39% difference. The market reacted with a -4.33% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 4.92 million USD, implying an increase of 36.84% EPS, and decrease of -7.90% in Revenue from the last quarter.
FAQ
For Q1 2026, Profound Medical Corp. Common Stock reported EPS of -$0.19, beating estimates by 25.75%, and revenue of $5.34M, 6.39% above expectations.
The stock price moved down -4.33%, changed from $7.16 before the earnings release to $6.85 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 4 analysts, Profound Medical Corp. Common Stock is expected to report EPS of -$0.26 and revenue of $4.92M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement